Cite
Liu P, Hu Z, DuBois BG, et al. Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. ACS Med Chem Lett. 2015;6(8):936-41doi: 10.1021/acsmedchemlett.5b00207.
Liu, P., Hu, Z., DuBois, B. G., Moyes, C. R., Hunter, D. N., Zhu, C., Kar, N. F., Zhu, Y., Garfunkle, J., Kang, L., Chicchi, G., Ehrhardt, A., Woods, A., Seo, T., Woods, M., van Heek, M., Dingley, K. H., Pang, J., Salituro, G. M., Powell, J., Terebetski, J. L., Hornak, V., Campeau, L. C., Lamberson, J., Ujjainwalla, F., Miller, M., Stamford, A., Wood, H. B., Kowalski, T., Nargund, R. P., & Edmondson, S. D. (2015). Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. ACS medicinal chemistry letters, 6(8), 936-41. https://doi.org/10.1021/acsmedchemlett.5b00207
Liu, Ping, et al. "Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes." ACS medicinal chemistry letters vol. 6,8 (2015): 936-41. doi: https://doi.org/10.1021/acsmedchemlett.5b00207
Liu P, Hu Z, DuBois BG, Moyes CR, Hunter DN, Zhu C, Kar NF, Zhu Y, Garfunkle J, Kang L, Chicchi G, Ehrhardt A, Woods A, Seo T, Woods M, van Heek M, Dingley KH, Pang J, Salituro GM, Powell J, Terebetski JL, Hornak V, Campeau LC, Lamberson J, Ujjainwalla F, Miller M, Stamford A, Wood HB, Kowalski T, Nargund RP, Edmondson SD. Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. ACS Med Chem Lett. 2015 Jul 10;6(8):936-41. doi: 10.1021/acsmedchemlett.5b00207. eCollection 2015 Aug 13. PMID: 26288697; PMCID: PMC4538435.
Copy
Download .nbib